NCT04029376

Study to Learn More About the Stomach and Intestine Complaints of Children Aged From 3 to 14 Years

Non-Interventional Study of Children Aged From 3 to 14 Years Suffering From Functional Gastrointestinal Complaints Classified According to the Rome Criteria

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,032 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 3 Years – 14 Years
• Healthy volunteers: Not accepted

Summary

In this observational study, researchers want to gain more information on children suffering from abnormal stomach and intestine function (based on the Rome criteria) and treated Iberogast. The Rome criteria have been developed by experts to support doctors to diagnose stomach and intestine disorders. This study will focus on children aged from 3 to 14 years in age treated by their doctor with the herbal drug Iberogast for their stomach and intestine complaints for one week. Researcher want to learn more about the efficacy of Iberogast by observing the changes of symptoms related to the stomach and intestine disorders. In addition information on the safety of the drug and how well the drug is tolerated by the patients will be collected.

Conditions

• Functional Gastrointestinal Disorders

Interventions

Type	Name	Description
DRUG	Iberogast®	The medication was applied 3 times 20 drops per day before or at meals with some liquid, ideally to one week insofar.

Timeline

• Start date: 2007-04-01
• Primary completion: 2008-10-01
• Completion: 2008-10-01
• First posted: 2019-07-23
• Last updated: 2019-09-19

Locations

1 site across 1 country: Germany